JETEMA THE TOXIN Trademark

Trademark Overview


On Tuesday, April 30, 2019, a trademark application was filed for JETEMA THE TOXIN with the United States Patent and Trademark Office. The USPTO has given the JETEMA THE TOXIN trademark a serial number of 79260523. The federal status of this trademark filing is REGISTERED as of Tuesday, August 11, 2020. This trademark is owned by JETEMA CO., LTD.. The JETEMA THE TOXIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for urogenital organs; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; allergy medications; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; analgesics; pharmaceutical preparations for respiratory organs; medicines for dental purposes; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches,...
jetema the toxin

General Information


Serial Number79260523
Word MarkJETEMA THE TOXIN
Filing DateTuesday, April 30, 2019
Status700 - REGISTERED
Status DateTuesday, August 11, 2020
Registration Number6121081
Registration DateTuesday, August 11, 2020
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THE TOXIN"
Goods and Servicespharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for urogenital organs; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; allergy medications; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; analgesics; pharmaceutical preparations for respiratory organs; medicines for dental purposes; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Translation of Words in MarkThe wording "JETEMA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJETEMA CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameJETEMA CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameJETEMA CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, December 19, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 1, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 1, 2020FINAL DISPOSITION PROCESSED
Wednesday, November 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 11, 2020REGISTERED-PRINCIPAL REGISTER
Friday, May 29, 2020NOTIFICATION PROCESSED BY IB
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 13, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 17, 2020ASSIGNED TO LIE
Wednesday, April 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2020REFUSAL PROCESSED BY IB
Wednesday, February 19, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 19, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 19, 2020NON-FINAL ACTION WRITTEN
Thursday, January 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 29, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, August 23, 2019REFUSAL PROCESSED BY IB
Friday, August 2, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 2, 2019REFUSAL PROCESSED BY MPU
Tuesday, July 16, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 15, 2019NON-FINAL ACTION WRITTEN
Monday, July 15, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, July 12, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 11, 2019NON-FINAL ACTION WRITTEN
Thursday, July 11, 2019ASSIGNED TO EXAMINER
Saturday, June 22, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, June 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 13, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB